業績(論文)

平成26年(2014)1~12月

原著

  1. Asaoka D, Nagahara A, Hojo M, Sasaki H, Shimada Y, Yoshizawa T, Osada T, Watanabe S. The Relationship between H. pylori Infection and Osteoporosis in Japan. Gastroenterol Res Pract. 2014; 2014: 340765.
  2. Asaoka D, Nagahara A, Matsumoto K, Hojo M, Watanabe S. Current perspectives on reflux laryngitis. Clin J Gastroenterol. 2014 Dec; 7(6): 471-5.
  3. Asaoka D, Nagahara A, Shimada Y, Matsumoto K, Ueyama H, Matsumoto K, Nakagawa Y, Takeda T, TanakaI, Sasaki H, Osada T, Hojo M, Watanabe S. Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori? Ther Clin Risk Manag. 2015 Mar 6; 11: 381-91.
  4. Beppu K, Osada T, Sakamoto N, Shibuya T, Matsumoto K, Nagahara A, Terai T, Ogihara T, Watanabe S. Optimal timing for resuming antithrombotic agents and risk factors for delayed bleeding after endoscopic resection of colorectal tumors. Gastroenterol Res Pract. 2014; 2014: 825179. Epub 2014 Dec 7.
  5. Fukuo Y, Yamashina S, Sonoue H, Arakawa A, Nakadera E, Aoyama T, Uchiyama A, Kon K, Ikejima K, Watanabe S. Abnormality of autophagic function and cathepsin expression in the liver from patients with non-alcoholic fatty liver disease. Hepatol Res. 2014 Sep; 44(9): 1026-36.
  6. Goto SP, Sakamoto N, Mitomi H, Murakami T, Ritsuno H, Ueyama H, Matsumoto K, Shibuya T, Osada T, Nagahara A, Ogihara T, Yao T, Watanabe S. Histological Distinction between the Granular and Nongranular Types of Laterally Spreading Tumors of the Colorectum. Gastroenterol Res Pract. 2014; 2014: Epub 2014 Aug 11.
  7. Hidaka Y, Mitomi H, Saito T, Takahashi M, Lee SY, Matsumoto K, Yao T, Watanabe S. Alteration in the Wnt/b-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type. Hum Pathol. 2013 Nov; 44(11): 2438-48.
  8. Higashihara Y, Kato J, Nagahara A, Izumi K, Konishi M, Kodani T, Serizawa N, Osada T, Watanabe S, Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer. Int J Oncol. 2014 Mar; 44(3): 662-8.
  9. Hojo M, Nagahara A, Asaoka D, Ueyama H, Shimada Y, Matsumoto K, Watanabe S. Symptoms of gastro-esophageal reflux disease: A comparative study between elderly and younger patients in Japan. Health, 2014; 6: 1700-1705.
  10. Ito T, Okubo H, Kokubu S, Miyazaki A, Ando H, Fujimura A, Watanabe S. Radiofrequency ablation combined with chemolipiodolization in a porcine liver: Comparison of the pharmacokinetic analysis with cisplatin powder and miriplatin. Hepatol Res. 2015 May; 45(5): 589-94. Epub 2014 Jul 28.
  11. Izumi K, Osada T, Sakamoto N, Kodani T, Higashihara Y, Ritsuno H, Shibuya T, Nagahara A, Ogihara T, Kikuchi K, Watanabe S. Frequent occurrence of fever in patients who have undergone endoscopic submucosal dissection for colorectal tumor, but bacteremia is not a significant cause. Surg Endosc. 2014 Oct; 28(10): 2899-904.
  12. Kagawa T, Oka A, Kobayashi Y, Hiasa Y, Kitamura T, Sakugawa H, Adachi Y, Anzai K, Tsuruya K, Arase Y, Hirose S, Shiraishi K, Shiina T, Sato T, Ting W, Tanaka M, Hayashi H, Kawabe N, Robinson PN, Zemojtel T, Mine T. Recessive inheritance of population-specific intronic LINE-1 insertion causes a Rotor syndrome phenotype. Hum Mutat 36: 327-332, 2014.
  13. Kawai T, Takahashi S, Suzuki H, Sasaki H, Nagahara A, Asaoka D, Matsuhisa T, Masaoaka T, Nishizawa T, Suzuki M, Ito M, Kurihara N, Omata F, Mizuno S, Torii A, Kawakami K, Ohkusa T, Tokunaga K, Mine T, Sakaki N. Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group). J Gastroenterol Hepatol. 2014 Dec; 29 Suppl 4: 29-32.
  14. Koido S, Ohkusa T, Nakae K, Yokoyama T, Shibuya T, Sakamoto N, Uchiyama K, Arakawa H, Osada T, Nagahara A, Watanabe S, Tajiri H. Factors associated with incomplete colonoscopy at a Japanese academic hospital. World J Gastroenterol. 2014 Jun 14; 20(22): 6961-7.
  15. Konishi M, Shibuya T, Mori H, Kurashita E, Takeda T, Nomura O, Fukuo Y, Matsumoto K, Sakamoto N, Osada T, Nagahara A, Ogihara T, Watanabe S. Usefulness of flexible spectral imaging color enhancement for the detection and diagnosis of small intestinal lesions found by capsule endoscopy. Scand J Gastroenterol. 2014 Apr; 49(4): 501-5. Epub 2014 Jan 13. PMID: 24417643
  16. Kumagai E, Shibuya T, Makino M, Murakami T, Takashima S, Ritsuno H, Ueyama H, Kodani T, Sasaki H, Matsumoto K, Sakamoto N, Osada T, Nagahara A, Ogihara T, Watanabe S. A Randomized Prospective Study of Bowel Preparation for Colonoscopy with Low-Dose Sodium Phosphate Tablets versus Polyethylene Glycol Electrolyte Solution. Gastroenterol Res Pract. 2014; 2014: 879749. Epub 2014 Sep 15
  17. Miwa H, Kusano M, Arisawa T, Oshima T, Kato M, Joh T, Suzuki H, Tominaga K, Nakada K, Nagahara A, Futagami S, Manabe N, Inui A, Haruma K, Higuchi K, Yakabi K, Hongo M, Uemura N, Kinoshita Y, Sugano K, Shimosegawa T. Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol. 2015 Feb; 50(2): 125-39.
  18. Morimoto T, Mitomi H, Saito T, Takahashi M, Murakami T, Sakamoto N, Yao T, Watanabe S. Distinct profile of HIF1a, PTCH, EphB2, or DNA repair protein expression and BRAF mutation in colorectal serrated adenoma. J Gastroenterol Hepatol. 2014 Jun; 29(6): 1192-9.
  19. Morinaga M, Osada T, Kon K, Kato J, Konishi M, Shibuya T, Sakamoto N, Nagahara A, Yao T, Fujime M, Watanabe S. Metastatic seminoma in the duodenum: diagnosis with endoscopy followed by successful treatment. Intern Med. 2014; 53(24): 2777-81.
  20. Nagahara A, Suzuki T, Nagata N, Sugai N, Takeuchi Y, Sakurai K, Miyamoto M, Inoue K, Akiyama J, Mabe K, Konuma I, Kamada T, Haruma K. A multicentre randomised trial to compare the efficacy of omeprazole versus rabeprazole in early symptom relief in patients with reflux esophagitis. J Gastroenterol Dec; 49(12): 1536-47. Epub 2013 Dec 24. PubMed PMID: 24366288; PubMed Central PMCID: PMC4258614.
  21. Nagahara A, Hojo M, Asaoka D, Sasaki H, Watanabe S. A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan. Scand J Gastroenterol. 2014 Apr; 49(4): 409-17.
  22. Nagahara A, Miwa H, Asaoka D, Shimada Y, Sasaki H, Matsumoto K, Osada T, Hojo M, Watanabe S. Pretreatment prediction of symptom response to proton pump inhibitor therapy. J Gastroenterol Hepatol. 2015 Mar; 30 Suppl 1: 25-30.
  23. Narita H, Genda T, Tsuzura H, Sato S, Kanemitsu Y, Ishikawa S, Kikuchi T, Hirano K, Iijima K, Wada R, Ichida T. Prediction of Iiver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy J Gastroenterol Hepatol 29: 137-143, 2014.
  24. Omata M, Nishiguchi S, Uemo Y, Mochizuki H, Izumi N, Ikeda F, Toyoda H, Yokosuka O, Nirei K, Genda T, Umemura T, Takehara T, Sakamoto N, Nishigaki Y, Nakane K, Toda N, Ide T, Yanase M, Hino K, Gao B, Garrison KL, Dvoyy-SobolH, Ishizaki A, Omote M, Brainard D, Konox S, Symonds WT, McHutchison JG, Yatsuhashi H, Mizokami M. Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection an open-label, phase 3 trial J Viral Hepat 78: 762-768, 2014.
  25. Ritsuno H, Sakamoto N, Osada T, Goto SP, Murakami T, Ueyama H, Mori H, Matsumoto K, Beppu K, Shibuya T, Nagahara A, Ogihara T, Watanabe S. Prospective clinical trial of traction device-assisted endoscopic submucosal dissection of large superficial colorectal tumors using the S-O clip. Surg Endosc. 2014 Nov; 28(11): 3143-9.
  26. Sakata Y, Tominaga K, Kato M, Takeda H, Shimoyama Y, Takeuchi T, Iwakiri R, Furuta K, Sakurai K, Odaka T, Kusunoki H, Nagahara A, Iwakiri K, Furuta T, Murakami K, Miwa H, Kinoshita Y, Haruma K, Takahashi S, Watanabe S, Higuchi K, Fujimoto K, Kusano M, Arakawa T; G-PRIDE studygroup, Collaborators: Mabe K, Kudo M, Oizumi H, Eto K, Muto S, Serikawa S, Sakamoto J, Hokari K, Nema H, Kakizaki S, Kudo T, Suzuki H, Takahashi K, Asaoka D, Hojyo M, Nakamura K, Tokunaga K, Matsumura T, Nakajima K, Sugimoto M, Yamada T, Maruyama Y, Kageoka M, Shirai N, Kodaira M, Tanigawa T, Kameda N, Uno H, Nakagawa K, Ochi M, Otani K, Oiso R, Ashida K, Yamashita H, Sakaguchi M, Makoto S, Kaseda S, Shiraki M, Saito O, Kondo T, Tomita T, Watari J, Fukui H, Abe T, Oku J, Kawaguchi M, Adachi K, Komazawa Y, Yuki M, Fujisawa T, Kushiyama Y, Kakuta E, Miyaoka Y, Morito Y, Furuta K, Eguchi Y, Kuroki S, Tsunada S, Ogata S, Yamanouchi K, Noda T, Tsuruoka N, Hasuda K, Oda Y, Murao T, Shiota S, Abe H, Yasaka S, Takeshima F. Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito. BMC Gastroenterol. 2014 Jul 2; 14: 116.
  27. Shibuya T, Watanabe S Diagnosis of Small-Intestinal Disease with Capsule Endoscopy Juntendo Medical Journal 2014. 60(2): 94-99
  28. Shimada Y, Nagahara A, Hojo M, Asaoka D, Sasaki H, Ueyama H, Matsumoto K, Watanabe S. Upper gastrointestinal mucosal injury and symptoms in elderly low-dose aspirin users. Gastroenterol Res Pract. 2015; 2015: 252963.
  29. Suyama M, Koike M, Asaoka D, Mori H, Oguro M, Ueno T, Nagahara A, Watanabe S, Uchiyama Y. Increased immunoreactivity of cathepsins in the rat esophagus under chronic acid reflux esophagitis. J Histochem Cytochem. 2014 Sep; 62(9): 645-60.
  30. Takeda T, Sugiyama M, Kanto T, Korenaga M, Mizogami M, Watanabe S. Establishment of a Practical Workflow Using a Next Generation Sequencer to Search for Novel SNPs Associated with the Anti-HCV Treatment Response Juntendo Medical Journal 2014. 60(6): 568-575.
  31. Tanaka Y, Nakazawa T, Komori S, Hidaka H, Okuwaki Y, Takada J, Watanabe M, Shibuya A, Minamino T, Yamamoto H, Kokubu S, Hayakawa K, Koizumi W. Radiotherapy for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels: efficacy and outcomes. J Gastroenterol Hepatol. 2014 Feb; 29(2): 352-7.
  32. Tashiro Y, Kawai M, Takehara K, Munakata S, Ishiyama S, Sugimoto K, Takahashi M, Kojima Y, Goto M, Tomiki Y, Shibuya T, Osada T, Watanabe S, Sakamoto K. Successful retrieval of a retained capsule endoscope with single incision laparoscopic surgery. Case Rep Gastroenterol. 2014 Jun 7; 8(2): 206-10.
  33. Tominaga K, Kato M, Takeda H, Shimoyama Y, Umegaki E, Iwakiri R, Furuta K, Sakurai K, Odaka T, Kusunoki H, Nagahara A, Iwakiri K, Furuta T, Murakami K, Miwa H, Kinoshita Y, Haruma K, Takahashi S, Watanabe S, Higuchi K, Kusano M, Fujimoto K, Arakawa T; G-PRIDE Study Group, Collaborators: Mabe K, Kudo M, Oizumi H, Eto K, Muto S, Serikawa S, Sakamoto J, Hokari K, Nema H, Kakizaki S, Kudo T, Suzuki H, Takahashi K, Asaoka D, Hojyo M, Nakamura K, Tokunaga K, Matsumura T, Nakajima K, Sugimoto M, Yamada T, Maruyama Y, Kageoka M, Shirai N, Kodaira M, Tanigawa T, Kameda N, Uno H, Nakagawa K, Ochi M, Otani K, Oiso R, Ashida K, Yamashita H, Sakaguchi M, Makoto S, Kaseda S, Shiraki M, Saito O, Kondo T, Tomita T, Watari J, Fukui H, Abe T, Oku J, Kawaguchi M, Adachi K, Komazawa Y, Yuki M, Fujisawa T, Kushiyama Y, Kakuta E, Miyaoka Y, Morito Y, Furuta K, Eguchi Y, Kuroki S, Tsunada S, Ogata S, Yamanouchi K, Noda T, Tsuruoka N, Hasuda K, Oda Y, Murao T, Shiota S, Abe H, Yasaka S, Takeshima F. A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. J Gastroenterol. 2014 Oct; 49(10): 1392-405.
  34. Tsuzura H, Genda T, Sato S, Murata A, Kanemitsu Y, Ishikawa S, Kikuchi T, Mori M, Hirano K, Iijima K, Wada R, Ichida T. Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesis Int J Mol Sci 15: 6556-6568, 2014.
  35. Ueyama H, Matsumoto K, Nagahara A, Hayashi T, Yao Takashi, Watanabe S Gastric adenocarcinoma of the fundic gland type (chief cell predominant type) Endoscopy 2014; 46: 153-157.
  36. Yamagiwa S, Kamimura H, Takamura M, Genda T, Ichida T, Nomoto M, Aoyagi Y. Presence of Antibodies against Self Human Leukocyte Antigen Class II Molecules in Autoimmune Hepatitis Int J Med Sci 11: 850-856, 2014.
  37. Yamagiwa S, Tamura Y, Takamura M, Genda T, Ichida T, Ishikawa T, Kamimura T, takahashi T, Suda T, Matsuda Y, Nomoto M, Aoyagi Y. Increase of fucosylated alpha-fetoprotein fraction at the onset of autoimmune hepatitis and acute liver failure Hepatol Res 44: 368-375, 2014.
  38. Arezzo A, Passera R, Saito Y, Sakamoto T, Kobayashi N, Sakamoto N, Yoshida N, Naito Y, Fujishiro M, Niimi K, Ohya T, Ohata K, Okamura S, Iizuka S, Takeuchi Y, Uedo N, Fusaroli P, Bonino MA, Verra M, Morino M. Systematic review and meta-analysis of endoscopic submucosal dissection versus transanal endoscopic microsurgery for large noninvasive rectal lesions. Surg Endosc. 2014 Feb; 28(2): 427-38.
  39. Sato M, Kato N, Tateishi R, Muroyama R, Kowatari N, Li W, Goto K, Otsuka M, Shiina S, Yoshida H, Omata M, Koike K. IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. J Gastroenterol. 2014; 49: 748-754.
  40. Nakagomi R, Tateishi R, Shiina S, Imamura J, Fujiwara N, Asaoka Y, Kondo Y, Koike K. Drastically reduced neoplastic seeding related to radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol. 2014; 109: 774-776.
  41. Ikeda M, Shiina S, Nakachi K, Mitsunaga S, Shimizu S, Kojima Y, Ueno H, Morizane C, Kondo S, Sakamoto Y, Asaoka Y, Tateishi R, Koike K, Arioka H, Okusaka T. Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma. Invest New Drugs. 2014; 32: 928-936.
  42. Asaoka Y, Tateishi R, Nakagomi R, Kondo M, Fujiwara N, Minami T, Sato M, Uchino K, Enooku K, Nakagawa H, Kondo Y, Shiina S, Yoshida H, Koike K. Frequency of and predictive factors for vascular invasion after radiofrequency ablation for hepatocellular carcinoma. PLoS One. 2014; 9: e111662.
  43. Fujiwara N, Tateishi R, Nakagawa H, Nakagomi R, Kondo M, Minami T, Sato M, Uchino K, Enooku K, Kondo Y, Asaoka Y, Shiina S, Yoshida H, Koike K. Slight elevation of high-sensitivity C-reactive protein to predict recurrence and survival in patients with early stage hepatitis C-related hepatocellular carcinoma. Hepatol Res. 2014 (in press).
  44. Fujiwara N, Tateishi R, Kondo M, Minami T, Mikami S, Sato M, Uchino K, Enooku K, Masuzaki R, Nakagawa H, Kondo Y, Asaoka Y, Shiina S, Yoshida H, Koike K. Cause-specific mortality associated with aging in patients with hepatocellular carcinoma undergoing percutaneous radiofrequency ablation. Eur J Gastroenterol Hepatol. 2014; 26: 1039-1046.
  45. Sato M, Kato N, Tateishi R, Muroyama R, Kowatari N, Li W, Goto K, Otsuka M, Shiina S, Yoshida H, Omata M, Koike K. Impact of PNPLA3 polymorphisms on the development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Hepatol Res. 2014; 44: E137-144.
  46. Minami T, Tateishi R, Shiina S, Fujiwara N, Mikami S, Sato M, Uchino K, Enooku K, Asaoka Y, Kondo Y, Yoshida H, Koike K. Spontaneous clearance of serum hepatitis C virus RNA during the clinical course of hepatocellular carcinoma in patients with chronic hepatitis C. Hepatol Res. 2014; 44: E32-37.
  47. Suzuki M, Sai JK, Shimizu T. Acute pancreatitis in children and adolescents. World J Gastrointest Pathophysiol. 2014; 5: 416-426.
  48. 佐藤俊輔,廿楽裕徳,玄田拓哉.AKR1B10.日本臨床 73: 394-397, 2015.
  49. 廿楽裕徳,玄田拓哉.SVR後の肝発癌.肝胆膵69: 883-888, 2014.
  50. 宮地隆史,池嶋健一,細谷聡子,新井久美子,今一義,山科俊平,渡辺純夫.脂肪性肝炎からの肝発癌過程における肝内自然免疫系細胞の発現動態 肝細胞特異的PTEN-KOマウスでの解析.アルコールと医学生物学,2014,32巻Page 40-44.
  51. 高嶋志在,池嶋健一,細谷聡子,今一義,山科俊平,渡辺純夫.グリシンによる肥満・2型糖尿病モデルKK-Ayマウスの脂肪性肝炎発症・進展抑制.アルコールと医学生物学,2014,32巻 Page 60-64.
  52. 今一義,池嶋健一,渡辺純夫.非B非C肝癌におけるオートファジー関連蛋白発現の変化.アルコールと医学生物学,2014,32巻Page 72-75.
  53. 山科俊平,稲見義宏,泉光輔,青山友則,内山明,今一義,鈴木聡子,池嶋健一,渡辺純夫.肝脂肪化とオートファジー機能障害.アルコールと医学生物学,2014,32巻Page 1-3.
  54. 松本紘平,上山浩也,松本健史,赤澤陽一,中川裕太,佐々木仁,嶋田裕慈,北條麻理子,永原章仁,八尾隆史,渡辺純夫.隆起型非混在乳頭腺癌の一例.Progress of Digestive Endoscopy (1348-9844)85巻Suppl, Pages 104, 2014. 6.
  55. 青山友則,内山明,柳沼礼子,福原京子,今一義,山科俊平,鈴木聡子,池嶋健一,渡辺純夫,デービット・ブレナー.肝星細胞におけるSOD1とNADPHオキシダーゼ(NOX)の相互関係とROS産生.アルコールと医学生物学,2014,32巻Page 56-59.
  56. 赤澤陽一,上山浩也,永原章仁,中川裕太,松本紘平,稲見義宏,松本健史,今一義,八尾隆史,渡辺純夫.CT gastrographyが診断に有用であった多発性胃粘膜下腫瘍の1例.日本消化器病学会雑誌(0446-6586)111巻10号,Page 1968-1975, 2014. 10.
  57. 倉本崇光,加藤順子,染谷秀忍,谷口源太郎,伊藤智康,村上敬,東原良恵,内山明,長田太郎,永原章仁,荻原達雄,八尾隆史,渡辺純夫.5年間の形態変化を観察し得た粘膜下腫瘍様胃癌の1例.Progress of Digestive Endoscopy, 2014, 84巻1号 Page 110-111, 9.
  58. 太田一樹,三好由里子,横須賀路子,平井三鈴,橋本周太郎,小島拓人,宮本彰俊,林康博,小林修,黒田寛之,渡辺純夫.サプリメント内服により食道潰瘍を生じた1例.Progress of Digestive Endoscopy 84, 1, 66-67.
  59. 平井三鈴,小林修,横須賀路子,三好由里子,橋本周太郎,小島拓人,宮本彰俊,林康博,太田一樹,黒田寛之,渡辺純夫.カプセル内視鏡が診断に有効であった日本海裂頭条虫症の1例.Progress of Digestive Endoscopy 84, 1, 128-129.
  60. 別府加寿子,坂本直人,武田武史,磯野彩,山本悠子,石井重登,小谷知弘,水井智和,猪狩功遺,折笠英紀,渡辺純夫.腹水を契機に発見された直腸肛門部悪性黒色腫の1例.Progress of Digestive Endoscopy (1348-9844)84巻1号 Page182-183, 18(2014. 06).
  61. 椎名秀一朗,佐藤隆久,近藤祐嗣,建石良介.State of the Art大腸癌肝転移に対するラジオ波焼灼術(RFA).Frontiers in Gastroenterology 2014; 19: 14-22.
  62. 三浦寛子,崔仁煥,福村由紀.膵管病変スクリーニングのためのMRCPについて. 臨床画像2014; 30: 1296-1300.
  63. 椎名秀一朗,建石良介,小俣政男.【内科疾患 最新の治療 明日への指針】(第2章)消化器転移性肝がん.内科2014; 113: 1087-1090.
  64. Mamat Osman,福村由紀,八尾隆史,石崎陽一,崔仁煥 膵・胆管合流異常症に合併した胆嚢肝様腺癌の1例.胆道2014; 28: 660-666.

総説

  1. Paik YH, Kim J, Aoyama T, De Minicis S, Bataller R, Brenner DA. Role of NADPH oxidases in liver fibrosis Antioxid Redox Signal, 2014; 20: 2854-2872.
  2. 青山友則,渡辺純夫.サーベイランス.Hepatology Practice 第5刊肝癌の診療を極める,2014, 120-124.
  3. 内山明,渡辺純夫.肝臓NAFLD・NASH.Annual Review消化器2014巻 Page 148-153.
  4. 今一義,渡辺純夫.脂肪肝と糖尿病の最前線.日本内科学会雑誌103, 12, 3118-3125.
  5. 稲見義宏,山科俊平,渡辺純夫.肝脂肪化におけるオートファジー機能障害と発癌.医学のあゆみ(0039-2359)251巻7号Page 555-560.
  6. 永原章仁,北條麻理子,浅岡大介,佐々木仁,嶋田裕慈,渡辺純夫.Helocobacter pylori除菌治療後の除菌判定はなぜ必要か.Helicobacter research 18巻1号:17-21, 2014. 60: 8-15, 2014.
  7. 永原章仁,北條麻理子,浅岡大介,佐々木仁,嶋田裕慈,渡辺純夫.【Helicobacter pylori除菌の負の部分を考える】Helicobacter pylori感染とGERD(解説/特集).Helicobacter Research (1342-4319)18巻5号Page 426-430 (2014.10).
  8. 永原章仁,北條麻理子,浅岡大介,松本健史,島田裕慈,佐々木仁,上山浩也,渡辺純夫.腸と健康慢性胃炎・胃癌とH. pylori(解説).順天堂醫事雑誌(2187-9737)60巻1号 Page 8-15 (2014. 02).
  9. 永原章仁,北條麻理子,渡辺純夫.機能性ディスペプシア.medicina 51, 1, 26-29, 2014.
  10. 永原章仁.北條麻理子.渡辺純夫.内視鏡所見から,FD治療につながる病態を評価・推察できるか?機能性ディスペプシア,39-44.
  11. 今一義,渡辺純夫.医学と医療の最前線脂肪肝と糖尿病の最前線.日本内科学会雑誌,2014; 103(12): 3118-3125.
  12. 今一義,渡辺純夫.NAFLD/NASHと酸化ストレス.酸化ストレスの医学,338-345.
  13. 坂本直人,立之英明,長田太郎,渡辺純夫.【スキルアップESD】視野確保とトラクションの工夫 バンドを用いたトラクションの工夫.消化器内視鏡(0915-3217)26巻9号 Page 1438-1442.
  14. 山科俊平.喫煙による肝細胞オートファジー抑制と細胞障害.消化器内科(1884-2895)58巻5号 Page 653-658.
  15. 上山浩也,八尾隆史.胃底腺型胃癌.臨床消化器内科(0911-601X)29巻6号 Page 747-751 (2014. 05).
  16. 上山浩也,八尾隆史,渡辺純夫.胃底腺型胃癌(内視鏡と病理).拡大内視鏡―極限に挑む2014, 10月 73-39.
  17. 上村直実,八尾隆史,上山浩也,藤澤貴史,矢田智之.H. pylori未感染胃癌の特徴(総説).Gastroenterological Endoscopy(0387-1207)56巻5号Page 1733-1743 (2014. 05).
  18. 森永真紀,今一義,池嶋健一,渡辺純夫.NAFLD/NASHの成因と病態.消化器の臨床,2014, 17巻1号Page 19-24.
  19. 大久保裕直.部分的脾動脈塞栓術(PSE)におけるC-arm CTの使用法.日本門脈圧亢進症学会雑誌(1344-8447)20巻2号 Page 147-150 (2014. 07).
  20. 大久保裕直,深田浩大,井草祐樹,宮崎招久,小倉加奈子,松本俊治,國分茂博.EOB-MRI登場後の乏血性肝細胞癌に対するRFAの意義.Liver Cancer 20; 83-88, 2014.
  21. 大久保裕直,深田浩大,井草祐樹,國分茂博,宮崎招久.ソラフェニブを含む集学的治療が奏功した巨大動静脈瘻合併進行肝細胞癌の一例.The Liver Cancer Journal 6: 272-273, 2014.
  22. 大久保裕直.ラジオ波焼灼術.日本内科学会雑誌103, 1, 78-86, 2014.
  23. 池嶋健一,渡辺純夫.【NASH―最新の知見―】基礎酸化ストレスとNASH.最新医学,2014,69巻9号 Page 1814-1820.
  24. 池嶋健一,渡辺純夫.NAFLDの診療・研究の進歩.日本消化器病学会雑誌,2014,111巻1号 Page 4-13.
  25. 八尾隆史,上山浩也.専門医のためのアトラス胃底腺型胃癌(図説).胃がんperspective(1883-3330)7巻2号 Page 112-116 (2014. 06).
  26. 林量司,國分茂博,浅野朗,山科俊平,川邉正人,宮崎招久,渡辺純夫,松川正明.医学と医療の最前線食道・胃静脈瘤治療への内科的アプローチ.日本内科学会雑誌(0021-5384)103巻5号,Page 1187-1194, 2014. 05.
  27. 崔仁煥.【悪性胆道狭窄に対する診断・治療の進歩】悪性胆道狭窄に対するCT,MRI診断.臨床消化器内科2014; 29: 1209-1216.

著書

  1. Genda T, Ichida T Liver Transplantation for primary biliary cirrhosis Ohira H ed.Autoimmune Liver Disease.Tokyo: Springer, 2014, pp. 287-300.
  2. 青山友則,北條麻理子,渡辺純夫.A型肝炎.消化器内科レジデントハンドブック第2版,2014; 438-439.
  3. 青山友則,北條麻理子,渡辺純夫.胆嚢腺筋症/胆嚢ポリープ.消化器内科レジデントハンドブック第2版,2014; 547-551.
  4. 内山明,北條麻理子,渡辺純夫.アルコール性肝障害.消化器内科レジデントハンドブック第2版,2014; 502-505.
  5. 内山明,北條麻理子,渡辺純夫.黄疸.消化器内科レジデントハンドブック第2版,2014; 32-35.
  6. 内山明,守慶,北條麻理子,渡辺純夫.肝血管腫.消化器内科レジデントハンドブック第2版,2014; 510-511.
  7. 編集者:渡辺純夫,永原章仁,北條麻理子.消化器疾患診療マニュアル.2014,日本医学館(東京).
  8. 編集者:渡辺純夫,北條麻理子.消化器内科レジデントハンドブック第二版. 2014,中外医学社(東京).
  9. 編集日本消化器病学会,作成委員長三輪洋人,作成委員永原章仁他,作成協力者北條麻理子他.機能性消化管疾患診療ガイドライン2014―機能性ディスペプシア.2014,南江堂(東京).
  10. 大久保裕直,富野康日己監.胆嚢胆石.内科外来処方navi.中外医学社,東京,p. 74. 2014.
  11. 國分茂博,監修沖田極.第4章管理・治療IVR最新医学・別冊「新しい診断と治療のABC44:肝硬変改訂第2版」.最新医学社,大阪,p. 163-172, 2014.
  12. 椎名秀一朗,近藤祐嗣,建石良介.4.ラジオ波焼灼術(RFA)―新たな展開と将来展望―.肝疾患Review 2014-2015.小俣政男監修,椎名秀一朗,坂本直哉,丸澤宏之編集,東京;日本メディカルセンター,2014; 61-66.
  13. 椎名秀一朗,建石良介,小俣政男.第2章 消化器 転移性肝がん.内科[特集]内科疾患 最新の治療 明日への指針.東京;南江堂,2014; 113: 1087-1090.
  14. 椎名秀一朗,建石良介.III大腸がん治療のpractice ⑬肝転移にRFAの適応はあるのか?.ガイドラインには載っていない消化管がんPractical Treatment.山田康秀,岩佐悟,本間義崇,髙島淳生,沖田南都子編集,東京;メジカルビュー社,2014; 107-110.
  15. 椎名秀一朗,建石良介.III治療編,A.経皮的治療,1経皮的局所療法とは.HEPATOLOGY PRACTICE[第5巻]肝癌の診療を極める 基本から最前線まで.金子周一ゲスト編集,竹原徹郎,持田智常任編集,東京;文光堂,2014; 146-151.
  16. 椎名秀一朗,近藤祐嗣,建石良介.IV治療 経皮的局所療法(PEIT, PMCT, RFA).消化器病診療 第2版.一般社団法人日本消化器病学会監修,「消化器病診療(第2版)」編集委員会編集,東京;医学書院,2014; 358-361.
  17. 椎名秀一朗.B肝臓 1経皮的ラジオ波焼灼術radiofrequency ablation (RFA) 消化器内科レジデントハンドブック第2版.渡辺純夫,北條麻理子編,東京;中外医学社,2014; 221-224.